Compounds > sodium selenosulfate
Page last updated: 2024-11-12

sodium selenosulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11424269
MeSH IDM0510032

Synonyms (13)

Synonym
sodium selenosulfate (na2seso3)
unii-t6519tq9v1
selenosulfuric acid (h2sseo3), disodium salt
25468-09-1
T6519TQ9V1 ,
selenosulfuric acid (h2sseo3), sodium salt (1:2)
sodium selenosulfate
sodium selenosulfate (na2sseo3)
disodium selenosulfate
Q27896965
selenosulfuric acid disodium salt
selenosulfuric acid (h2sseo3), disodium salt (1:2)
DTXSID701033629

Research Excerpts

Effects

ExcerptReferenceRelevance
"Sodium selenosulfate has been extensively used as a precursor of selenide ions in the preparation of nano Se-containing compounds. "( Effect of sodium selenosulfate on restoring activities of selenium-dependent enzymes and selenium retention compared with sodium selenite in vitro and in vivo.
Liu, Q; Peng, D; Zhang, J, 2007)		2.18

Toxicity

ExcerptReferenceRelevance
" The low-dose sodium selenite caused growth suppression and hepatotoxicity which were aggravated by the high-dose, leading to 40% mortality rate, but no toxic symptoms were observed in the two sodium selenosulfate groups."( Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity.
Li, J; Ni, L; Sun, K; Wang, D; Wang, X; Zhang, J, 2012)		2.01
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
selenious acid
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.		2.1310selenium oxoacid
cadmium sulfide
[no description available]		2.0310cadmium molecular entity
sodium selenite
disodium selenite : An inorganic sodium salt composed of sodium and selenite ions in a 2:1 ratio.		7.7430inorganic sodium salt;
selenite salt		nutraceutical
cyanates
Cyanates: Organic salts of cyanic acid containing the -OCN radical.. cyanates : Salts and esters of cyanic acid, HOC#N; compounds carrying the cyanate functional group -O-C#N.. isocyanates : Organonitrogen compounds that are derivatives of isocyanic acid; compounds containing the isocyanate functional group -N=C=O (as opposed to the cyanate group, -O-C#N).		1.9510
selenium
Selenium: An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.		7.9140chalcogen;
nonmetal atom		micronutrient
ConditionIndicatedRelationship StrengthStudiesTrials
Bladder Cancer
[description not available]		02.1310
Urinary Bladder Neoplasms
Tumors or cancer of the URINARY BLADDER.		02.1310
Leucocythaemia
[description not available]		02.0410
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)		07.0410
Cholera Infantum
[description not available]		02.0710
Hepatocellular Carcinoma
[description not available]		02.4620
Experimental Hepatoma
[description not available]		02.4620
Diarrhea
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.		02.0710
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.		02.4620
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.		02.0410
Ascites
Accumulation or retention of free fluid within the peritoneal cavity.		02.0410